The promise of genetically engineered mice for cancer prevention studies

Jeffrey E Green1, Tamaro Hudson

  • 1Transgenic Oncogenesis Group, Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, Besthesda, MD 20892, USA. jegreen@mail.nih.gov

Insights

Genetically engineered mouse models accurately mimic human cancers, offering a rapid system to test cancer prevention drugs and their mechanisms. Validating these models aids in selecting effective agents for clinical trials and combination therapy testing.

Area of Science:

  • Oncology
  • Genetics
  • Pharmacology

Background:

  • Sophisticated genetic technologies enable the creation of mouse models that replicate key aspects of human cancer development.
  • These genetically engineered mouse models (GEMMs) are crucial for advancing cancer research.

Purpose of the Study:

  • To highlight the utility of GEMMs in evaluating chemopreventive agents.
  • To emphasize the role of GEMMs in understanding drug mechanisms and guiding clinical applications.

Main Methods:

  • Utilizing GEMMs that recapitulate human oncogenesis.
  • Assessing the efficacy of chemopreventive agents within these models.

Main Results:

  • GEMMs provide relevant and rapid systems for efficacy determination.
  • These models facilitate the study of chemopreventive mechanisms of action.

Conclusions:

  • Validated GEMMs are essential for selecting appropriate agents for clinical trials.
  • GEMMs support the testing of novel combination therapies for cancer treatment.